StockNews.com Begins Coverage on ClearSign Technologies (NASDAQ:CLIR) – Defense World
Posted by admin on Jul 16th, 2022 
Stock analysts at StockNews.com initiated coverage on shares of ClearSign Technologies (NASDAQ:CLIR – Get Rating) in a research note issued on Saturday. The firm set a “sell” rating on the technology company’s stock.
ClearSign Technologies stock opened at $1.16 on Friday. The firm has a market cap of $42.27 million, a PE ratio of -5.06 and a beta of 1.06. The firm’s 50 day moving average price is $1.21 and its two-hundred day moving average price is $1.29. ClearSign Technologies has a twelve month low of $1.00 and a twelve month high of $4.50.
ClearSign Technologies (NASDAQ:CLIR – Get Rating) last released its quarterly earnings data on Thursday, June 2nd. The technology company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. During the same quarter last year, the business posted ($0.07) earnings per share. Equities analysts anticipate that ClearSign Technologies will post -0.16 EPS for the current fiscal year.
In other ClearSign Technologies news, Director Robert Thurston Sr Hoffman, Sr. purchased 1,591,594 shares of the company’s stock in a transaction dated Friday, July 8th. The shares were bought at an average price of $1.11 per share, for a total transaction of $1,766,669.34. Following the purchase, the director now directly owns 7,583,234 shares in the company, valued at approximately $8,417,389.74. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other ClearSign Technologies news, Director Robert Thurston Sr Hoffman, Sr. purchased 1,591,594 shares of the company’s stock in a transaction dated Friday, July 8th. The shares were bought at an average price of $1.11 per share, for a total transaction of $1,766,669.34. Following the purchase, the director now directly owns 7,583,234 shares in the company, valued at approximately $8,417,389.74. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bruce Alan Pate acquired 45,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 14th. The shares were purchased at an average cost of $1.12 per share, with a total value of $50,400.00. Following the completion of the acquisition, the director now owns 150,000 shares in the company, valued at approximately $168,000. The disclosure for this purchase can be found here. Company insiders own 25.10% of the company’s stock.
A hedge fund recently raised its stake in ClearSign Technologies stock. Traynor Capital Management Inc. increased its position in shares of ClearSign Technologies Co. (NASDAQ:CLIR – Get Rating) by 61.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,000 shares of the technology company’s stock after buying an additional 13,000 shares during the period. Traynor Capital Management Inc. owned 0.11% of ClearSign Technologies worth $46,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 8.42% of the company’s stock.
(Get Rating)
ClearSign Technologies Corporation designs and develops products and technologies to enhance operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States and the People's Republic of China. Its ClearSign Core Burner Technology consists of an industrial burner body and a downstream porous ceramic structure or metal flame stabilizing device; ClearSign Core Plug & Play technology provides direct burner replacement for traditional refinery process heaters; and ClearSign Eye Flame Sensor, an electrical flame sensor for industrial applications.
Receive News & Ratings for ClearSign Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ClearSign Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
Conformis (NASDAQ:CFMS) Coverage Initiated at StockNews.com
Cancer Genetics (NASDAQ:CGIX) Coverage Initiated by Analysts at StockNews.com